Advertisement
Journal Home
Search for
Cover Image

Current Issue

August 2010 | Vol. 9, No. 8

Top Meeting Reports

MMF Tops Azathioprine for Curbing Lupus Relapse, Phase III Trial Finds

Rheumatologists Tire of Short-Term Patches to Fee Schedule

Stem-Cell Transplant May Drive Remission in Severe SLE

More Reports >>

GMNN Today's News
audio icon    Policy & Practice
video icon    Videos
Blog    EGMN Blog
facebook      Facebook

Colleague Commentary

Ask the Expert:
Dr. Philip J. Hashkes discusses the need to address the increased risk for early osteoporosis among children with JIA, pediatric SLE, or juvenile dermatomyositis.

Implementing Health Reform
Dr. J. Fred Ralson answers our questions on the Independent Payment Review Advisory Board, the 15 peopl charged with slowing the growth of Medicare spending.

Commentary
Dr. Christopher Notte and Dr. Neil Skolnik discuss ways to improve meaningful use criteria for electronic health records.

Inside Rheum
Dr. Larry Greenbaum discusses the range of family involvement in his patients' disease management.

Trends

Rheumatologists Hit Hard by Loss of Consultation Codes

Daily News from Elsevier Global Medical News

Activate Your Online Access to Rheumatology News

Sign-up for your free access to Rheumatology News online. Browse, search, and share full-text articles with colleagues and patients. For the latest news and research reports from medical meetings and expert commentary, sign up or click here for more information.

Already have a username and password? You may be asked to answer a few questions. Click here to log in.

First-time User? Create an account here, and request free access.

Purchase a print subscription now!

Request Free Access to Full-text

Talk Back

Talk Back

Poll

Is the American College of Rheumatology doing enough to limit the funding it accepts from the pharmaceutical and device industries?

Yes
No



Why or why not?
Respond to Talk Back

STATISTICS

Vital Signs: Biologic DMARDs Among Top 10 Therapeutic Classes

 

CME Library
Optimizing Therapy in RA: Update on Long-Term Strategies
Supported by
UCB Pharma


Biologic Agents: Practice Implications and Improved Patient Outcomes
Supported by
Roche


MORE

 

Medical Education Library
A Novel TNF Inhibitor for RA: An Update
Sponsored by
UCB


MORE

Advertisement